Published in Onkologie on November 08, 2007
PharmGKB summary: very important pharmacogene information for CYP3A5. Pharmacogenet Genomics (2012) 0.87
Genetic structure of Europeans: a view from the North-East. PLoS One (2009) 3.46
Measurement of erythrocyte inosine triphosphate pyrophosphohydrolase (ITPA) activity by HPLC and correlation of ITPA genotype-phenotype in a Caucasian population. Clin Chem (2005) 1.96
Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit (2009) 1.68
The peopling of Europe and the cautionary tale of Y chromosome lineage R-M269. Proc Biol Sci (2011) 1.52
Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia. Dement Geriatr Cogn Disord (2006) 1.49
cDNA microarray analysis reveals new candidate genes possibly linked to side effects under mycophenolate mofetil therapy. Transplantation (2004) 1.48
Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury. Clin Chem (2013) 1.48
Differences in nucleotide hydrolysis contribute to the differences between erythrocyte 6-thioguanine nucleotide concentrations determined by two widely used methods. Clin Chem (2003) 1.45
Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis. J Neurol Neurosurg Psychiatry (2012) 1.41
The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy. J Am Soc Nephrol (2002) 1.38
Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial. Transplantation (2008) 1.34
Therapeutic drug monitoring of mycophenolate mofetil in transplantation. Ther Drug Monit (2006) 1.30
Gastrointestinal side effects of mycophenolic acid in renal transplant patients: a reappraisal. Nephrol Dial Transplant (2007) 1.30
Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol Psychiatry (2004) 1.26
Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood. Clin Chem (2002) 1.23
Support for neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia. Biol Psychiatry (2008) 1.20
Analysis of ITPA phenotype-genotype correlation in the Bulgarian population revealed a novel gene variant in exon 6. Ther Drug Monit (2007) 1.17
Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus. Clin Chem (2005) 1.14
Genetic characterization of northeastern Italian population isolates in the context of broader European genetic diversity. Eur J Hum Genet (2012) 1.12
Etiology of Balkan endemic nephropathy and associated urothelial cancer. Am J Nephrol (2006) 1.10
Acyl glucuronide drug metabolites: toxicological and analytical implications. Ther Drug Monit (2003) 1.08
Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea. Transplantation (2003) 1.06
Proteome of conidial surface associated proteins of Aspergillus fumigatus reflecting potential vaccine candidates and allergens. J Proteome Res (2006) 1.04
AmpliChip CYP450 GeneChip: a new gene chip that allows rapid and accurate CYP2D6 genotyping. Ther Drug Monit (2006) 1.04
Variation in the protocadherin gamma A gene cluster. Genomics (2003) 1.03
Distinguishing the co-ancestries of haplogroup G Y-chromosomes in the populations of Europe and the Caucasus. Eur J Hum Genet (2012) 1.03
Cognitive impairment and dementia in elderly people living in rural Benin, west Africa. Dement Geriatr Cogn Disord (2009) 1.02
Influencing factors of dsDNA dye (high-resolution) melting curves and improved genotype call based on thermodynamic considerations. Anal Biochem (2008) 1.01
In vitro gender differences in neuronal survival on hypoxia and in 17beta-estradiol-mediated neuroprotection. J Cereb Blood Flow Metab (2005) 1.01
MODULAR ANALYTICS: A New Approach to Automation in the Clinical Laboratory. J Autom Methods Manag Chem (2005) 1.00
Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients. Clin Chem (2007) 0.99
Genomic markers for ovarian cancer at chromosomes 1, 8 and 17 revealed by array CGH analysis. Tumori (2009) 0.98
N-acetylcysteine decreases lactate signal intensities in liver tissue and improves liver function in septic shock patients, as shown by magnetic resonance spectroscopy: extended case report. Crit Care (2004) 0.98
Genome-wide gene expression profiles of thyroid carcinoma: Identification of molecular targets for treatment of thyroid carcinoma. Oncol Rep (2008) 0.98
Genetic differences between five European populations. Hum Hered (2010) 0.98
Proteins identified as targets of the acyl glucuronide metabolite of mycophenolic acid in kidney tissue from mycophenolate mofetil treated rats. Biochimie (2006) 0.97
Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study. Clin Chem (2005) 0.97
Diagnostic criteria for Balkan endemic nephropathy: proposal by an international panel. Ren Fail (2007) 0.97
Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer. Clin Biochem (2008) 0.97
Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk. Obesity (Silver Spring) (2013) 0.96
Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients. Ther Drug Monit (2002) 0.95
Pharmacokinetics of mycophenolate mofetil in hematopoietic stem cell transplant recipients. Ther Drug Monit (2007) 0.94
Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability. Expert Opin Drug Metab Toxicol (2005) 0.94
Analytic aspects of monitoring therapy with thiopurine medications. Ther Drug Monit (2004) 0.93
Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy. J Nephrol (2004) 0.93
Identification of protein targets for mycophenolic acid acyl glucuronide in rat liver and colon tissue. Proteomics (2004) 0.93
Identification of novel autoantigen in the synovial fluid of rheumatoid arthritis patients using an immunoproteomics approach. PLoS One (2013) 0.92
Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: implications for drug exposure in renal allograft recipients. Clin Pharmacol Ther (2006) 0.91
Bulgarians vs the other European populations: a mitochondrial DNA perspective. Int J Legal Med (2011) 0.91
Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11beta-hydroxysteroid dehydrogenase type 1. Diabetes (2009) 0.90
Immuno-reactive molecules identified from the secreted proteome of Aspergillus fumigatus. J Proteome Res (2010) 0.90
Biomarkers as a tool for management of immunosuppression in transplant patients. Ther Drug Monit (2010) 0.90
Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN). Clin Biochem (2005) 0.90
Gene expression in peripheral blood of patients with hypertension and patients with type 2 diabetes. J Cardiovasc Med (Hagerstown) (2014) 0.88
Pharmacogenetic screening for drug therapy: from single gene markers to decision making in the next generation sequencing era. Pathology (2012) 0.88
Association study in the 5q31-32 linkage region for schizophrenia using pooled DNA genotyping. BMC Psychiatry (2008) 0.88
An open prospective pilot study on the use of rapamycin after penetrating high-risk keratoplasty. Transplantation (2006) 0.87
Circulating cytokines as markers of systemic inflammatory response in severe community-acquired pneumonia. Clin Biochem (2004) 0.87
Liquid chromatography-tandem mass spectrometry or automated immunoassays: what are the future trends in therapeutic drug monitoring? Clin Chem (2012) 0.87
Proteomics approach to identify the interacting partners of cellular prion protein and characterization of Rab7a interaction in neuronal cells. J Proteome Res (2011) 0.86
Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation. Ther Drug Monit (2016) 0.86
Introduction of the QF-PCR analysis for the purposes of prenatal diagnosis in Bulgaria--estimation of applicability of 6 STR markers on chromosomes 21 and 18. Prenat Diagn (2004) 0.86
High-throughput tissue microarray analysis of CMYC amplificationin urinary bladder cancer. Int J Cancer (2005) 0.86
Y-chromosome diversity in modern Bulgarians: new clues about their ancestry. PLoS One (2013) 0.86
Pre-analytical effects of different lithium heparin plasma separation tubes in the routine clinical chemistry laboratory. Clin Chem Lab Med (2011) 0.85
Pharmacokinetics of meropenem in critically ill patients with severe infections. Ther Drug Monit (2013) 0.85
Extracellular Toxoplasma gondii tachyzoites do not require carbon source uptake for ATP maintenance, gliding motility and invasion in the first hour of their extracellular life. Int J Parasitol (2011) 0.84
No association between MDR1 (ABCB1) 2677G>T and 3435C>T polymorphism and sporadic colorectal cancer among Bulgarian patients. J Cancer Res Clin Oncol (2007) 0.84
Clinical utility of a new enzymatic assay for determination of mycophenolic acid in comparison with an optimized LC-MS/MS method. Ther Drug Monit (2009) 0.84
Long-term pharmacokinetics of mycophenolic acid in pediatric renal transplant recipients over 3 years posttransplant. Ther Drug Monit (2008) 0.84
NAT2*5/*5 genotype (341T>C) is a potential risk factor for schistosomiasis-associated bladder cancer in Egyptians. Ther Drug Monit (2005) 0.83
Thrombopoietin inhibits nerve growth factor-induced neuronal differentiation and ERK signalling. Cell Signal (2007) 0.83
Pharmacokinetics and safety of lidocaine and monoethylglycinexylidide in liposuction: a microdialysis study. Plast Reconstr Surg (2004) 0.83
Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population. J Affect Disord (2009) 0.83
Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer's disease patients. J Neurochem (2012) 0.83
Convergent patterns of association between phenylalanine hydroxylase variants and schizophrenia in four independent samples. Am J Med Genet B Neuropsychiatr Genet (2009) 0.83
Alzheimer's disease: genetic polymorphisms and rate of decline. Dement Geriatr Cogn Disord (2012) 0.82
Two for typing: homogeneous combined single-nucleotide polymorphism scanning and genotyping. Clin Chem (2005) 0.82
Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic acid. Clin Chem (2003) 0.82
Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of the human kidney. Nephrol Dial Transplant (2007) 0.82
Characterization of the inosine triphosphatase (ITPA) gene: haplotype structure, haplotype-phenotype correlation and promoter function. Ther Drug Monit (2008) 0.82